Roxadustat for bone and brain health in dialysis patients
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether roxadustat, a medicine for anemia, can also help with bone problems and mood or thinking issues in people on hemodialysis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be over 18 years old.
- You must be willing to sign a consent form.
- You must have end-stage kidney disease and have been on hemodialysis for at least 3 months.
- You cannot be pregnant or breastfeeding.
- You cannot have a current cancer diagnosis.
- You cannot have a history of certain blood disorders or anemia from causes other than kidney disease.
- You cannot have taken certain bone medications (like bone-building or bone-breaking drugs) in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether roxadustat can help improve heart health, nutrition, and reduce inflammation in people on hemodialysis. It may offer a new treatment option for anemia related to kidney disease.
This study tests an investigational drug (RVX000222) to see if it helps people with kidney failure who are on dialysis. The drug is given in two parts and may help improve heart health, which is often a concern for dialysis patients.
This study looks at whether a drug called roxadustat helps people who have heart failure, anemia, and moderate-to-severe chronic kidney disease. The trial focuses on people who have already been taking roxadustat for more than a year.
This study tests whether a pill called roxadustat can help improve kidney oxygen levels in people with diabetes-related kidney disease and anemia. It may help boost your red blood cells and improve how your kidneys work.
This trial tests whether a drug called roxadustat (taken as a pill) can help people on dialysis who also have sarcopenia (loss of muscle strength and mass). It aims to see if the drug improves muscle health and anemia.
This trial tests a pill called roxadustat to help treat anemia in people with myelodysplastic syndromes (MDS). It might reduce the need for blood transfusions and improve energy levels.
Hear when a new Kidney Failure, Chronic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.